In October 2021, Sopharma Trading will present for the first time on the Bulgarian market the Okitask products of the Italian bio-pharmaceutical company Dompé. Partnering with Dompé, Sopharma Trading’s ambition to lead the evolution of the healthcare sector in Bulgaria meets the Italian company’s commitment to achieving medical and scientific progress through research and innovation in the field of basic care.
Okitask products are suitable for various types of pain – headache, toothache, muscle, and joint pain, and symptomatic treatment of fever. In our country will be presented 2 innovative products – sachets and tablets with an easy intake without water for the granules.
„Sopharma Trading continues to actively expand its exclusive product portfolio and we are happy to be joined by Okitask products. Our partnership with the Italian bio-pharmaceutical company Dompé will provide Bulgarian consumers with access to 2 innovative and popular products. This is another step in our ambitious plan to turn our company into a leader in terms of exclusive products“, commented Plamen Kolev, Executive Director Exclusive Portfolio at Sopharma Trading.
The pharmaceutical history of the Italian brand Dompé began 130 years ago as a production laboratory in Milan. Today, the company is focused on creating innovative products through its own research and an open ecosystem for innovation. The company offers a number of OTC products, food supplements, medical devices, and cosmetics in the field of primary care, as well as products for the treatment of rare diseases. Currently, Dompé develops its production in a factory with an area of 160 000 sq.m. in L’Aquila, Italy, and their successful development and production activity lead to over 532 million revenue for 2020.